TD Cowen analyst Phil Nadeau maintained a Buy rating on Biogen (BIIB – Research Report) today and set a price target of $275.00. The company’s shares closed yesterday at $164.89. According to TipRanks ...
Analyst Michael Yee of Jefferies maintained a Buy rating on Biogen (BIIB – Research Report), retaining the price target of $250.00. Michael Yee has given his Buy rating due to a combination of factors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
